|
Volumn 58, Issue 5, 2008, Pages 659-661
|
Will Stem Cell Biology Generate New Therapies for Parkinson's Disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA SYNUCLEIN;
BRAIN DERIVED NEUROTROPHIC FACTOR;
COPPER ZINC SUPEROXIDE DISMUTASE;
FRACTALKINE;
LEVODOPA;
VASCULOTROPIN;
AMYOTROPHIC LATERAL SCLEROSIS;
BRAIN REGION;
BRAIN TRANSPLANTATION;
DISEASE COURSE;
DOPAMINERGIC NERVE CELL;
DRUG EFFICACY;
GENE MUTATION;
HUMAN;
HUNTINGTON CHOREA;
LEWY BODY;
MESENCEPHALON;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SEROTONINERGIC NERVE CELL;
SHORT SURVEY;
STEM CELL;
STEM CELL TRANSPLANTATION;
SYMPTOMATOLOGY;
BRAIN TISSUE TRANSPLANTATION;
FETUS;
HUMANS;
PARKINSON DISEASE;
STEM CELLS;
|
EID: 44649149562
PISSN: 08966273
EISSN: None
Source Type: Journal
DOI: 10.1016/j.neuron.2008.05.016 Document Type: Short Survey |
Times cited : (27)
|
References (14)
|